February 28, 2015 2:48 PM ET

Pharmaceuticals

Company Overview of Macleod Pharmaceuticals, Inc.

Company Overview

As of October 1, 2012, Macleod Pharmaceuticals, Inc. was acquired by Neogen Corp. Macleod Pharmaceuticals, Inc. engages in the research, development, and manufacture of UNIPRIM oral equine antibiotic powder and Apple UNIPRIM flavored oral equine antibiotic powder. It also markets INTRACELL hydrophilic wound dressing for various species. The company distributes its products through distributors in the United States and Canada. The company was founded in 1989 and is based in Fort Collins, Colorado.

2600 Canton Court

Suite C

Fort Collins, CO 80525

United States

Founded in 1989

Phone:

970-482-7254

Fax:

970-482-7454

Key Executives for Macleod Pharmaceuticals, Inc.

Macleod Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Biotherapies, Inc. United States
Health Decisions, Inc. United States
TrimLife Inc. United States
Nulab, Inc. United States
Alva-Amco Pharmacal Companies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Macleod Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.